| Wednesday, February 27 |
| 2:00 pm - 3:30 pm | |
| |
Pharma, Biotech and Life Sciences Workshop
(90 mins)
View Participants
The pharmaceutical industry and life sciences in general have begun to depend on in silico experiments as critical elements in the path to discovery. This has enabled exploration that is only limited by the ability to access sufficient computing resources and to store and manage the resultant mountain of data. Recent discussions of the issues facing pharma, biotech and life sciences organizations as they deploy and manage their Grids have centered on:
• Real time data delivery
• Use cases for shared memory caches
• Challenges around sharing a grid
• Tools and processes for application on-boarding
• Global manageability
• Standards to enable grid interoperability
The workshop provides individuals in the pharma, biotech and life sciences industries an opportunity to discuss and understand these issues in a forum that includes their peers and experts on Grids and cluster computing, data management, and storage.
The workshop will begin with several short presentations on generic issues of interest to the pharma, biotech and life sciences community. These presentations will be followed by panel-led discussions of the key issues that participants want to explore in greater detail.
Confirmed Speakers include:
1. Ian Stokes-Rees, Harvard Medical School, Structural Biology Grid Computing Group
2. Steve Litster, Novartis Institutes of BioMedical Research
3. Vincent Breton, CNRS
We hope that the discussion identifies a series of best practices and expect that these best practices will contribute to a more detailed discussion of the priorities that the Open Grid Forum should take in its work on standards for Grid computing.
The main products of this workshop will be:
1. A White Paper on solving the issues pharma, biotech and life sciences organizations face in using grids. This paper will summarize the discussion at the workshop.
2. Initial discussions of how to create an ongoing financial services group to work with OGF to resolve the issues addressed in the workshop.
This workshop will provide an opportunity to address the Grid computing issues facing pharma, biotech and life sciences organizations and to meet with experts who are thinking about them and working on innovative solutions. If these issues are of concern to you, please attend the workshop.
Additional Takeaways:
• A better understanding of the generic issues that cluster and Grid users in the pharma, biotech, and life sciences industry believe are the “top level� challenges they face
• An opportunity to discuss these challenges with leading experts in the Grid community.
• Information about how “fellow� pharma, biotech, and life sciences adopters are addressing these challenges and resolving the “problem points� they face
• Feedback from Grid experts about how they believe the key pharma, biotech, and life sciences challenges can be ameliorated
• Excellent opportunities to raise challenges face-to-face with peers and Grid gurus, including small group discussions and cross-industry sessions.
• Rare insights from Grid experts, vendors, and other users about future trends in Grid adoption
• A chance to hear about the best practices in place at end-user organizations in pharma, biotech, and life sciences
Location: Ballroom A/B/C
|
| |
| |
|
| |
| | Slides: BioTeam |
| | Slides: Drug discovery on the grid: the WISDOM initiative… and beyond |
| | Slides: NIBR : Where does it hurt? Novartis |
| | Slides: Structural Biology on the Grid Harvard |
| | Document (Word): Workshop Notes |